Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy.
Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy. The new markets represent the extension of an existing distribution agreement between the two companies addressing CADstream sales in the European Union. Merge has been ramping up educational efforts for EU radiologist, holding workshops on breast MRI in Germany and the U.K., and scheduling a course this month in France in November. CADstream joined the Merge portfolio with the acquisition earlier this year of its developer, Confirma, which is now the Merge CAD business unit. CADstream automates the analysis and interventional guidance of MRI studies. The company claims 1200 installed sites worldwide.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.